Mark F. Brady, MD
Mark F. Brady, MD
Director
University of Buffalo
University at Buffalo
Biostatistics
Buffalo,
NY
USA
14260-1608
Papers:
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination with Bevacizumab Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian